financetom
Business
financetom
/
Business
/
Novartis to acquire Avidity Biosciences for $12 billion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Novartis to acquire Avidity Biosciences for $12 billion
Oct 26, 2025 10:18 AM

Oct 26 (Reuters) - Swiss drugmaker Novartis on

Sunday said it agreed to acquire Avidity Biosciences ( RNA ) for $12

billion.

(Reporting by Angela Christy in Bengaluru)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Leggett & Platt Q2 sales beat estimates, EPS rises
Leggett & Platt Q2 sales beat estimates, EPS rises
Jul 31, 2025
Overview * Leggett & Platt ( LEG ) Q2 sales of $1.1 bln beat analyst expectations * Adjusted EPS for Q2 rises to $.30, up $.01 yr/yr * Co reduced debt by $143 mln, improving balance sheet Outlook * Leggett & Platt ( LEG ) maintains 2025 sales and adjusted EPS guidance Result Drivers * SOFT DEMAND - Volume decreased...
Corcept Therapeutics Q2 revenue misses estimates
Corcept Therapeutics Q2 revenue misses estimates
Jul 31, 2025
Overview * Corcept Q2 2025 revenue grows to $194.4 mln, missing analyst expectations, as per LSEG data * Net income for Q2 2025 slightly declines to $35.1 mln * The pharma company repurchased $115.4 mln of common stock in Q2 2025 Outlook * Corcept guides 2025 revenue at $850 mln to $900 mln * Company expects improved vendor performance to...
AMH Q2 rents up 8%, raises Core FFO full-year guidance
AMH Q2 rents up 8%, raises Core FFO full-year guidance
Jul 31, 2025
Overview * AMH Q2 rents and other single-family property revenues up 8% yr/yr to $457.5 mln * Net income rises to $105.6 mln, $0.28 per diluted share, from $92.1 mln * Core FFO per share up 4.9% yr/yr Outlook * AMH raises full-year 2025 Core FFO attributable to common share and unit holders guidance to $1.84-$1.88 per share * Company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved